(Q58896377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Marco Bertolotti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

A Dell'Utri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

U Avico

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

E Sternieri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

Drug and Alcohol Dependence

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

211-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

Effects of long-term therapy with naltrexone on body weight in obesity

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Effect of liver cirrhosis on the systemic availability of naltrexone in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Clinical pharmacokinetics of narcotic agonist-antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Naltrexone reverses bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Interaction between thioridazine and naltrexone.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Differential Effects of Oral Contraceptive Steroids on the Metabolism of Benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Inhibition of antipyrine metabolism by low-dose contraceptives with gestodene and desogestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Randomised crossover trial of naltrexone in uraemic pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Effects of Long-Term Treatment with Naltrexone on Hepatic Enzyme Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Naltrexone Pharmacology, Pharmacokinetics, and Metabolism: Current Status

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Quantitative determination of naltrexone and betanaltrexol in human plasma using electron capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

Opioid antagonist-induced receptor upregulation: effects of concurrent agonist administration

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2898%2900098-2

7 January 2021

10.1016/S0376-8716(98)00098-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9839147%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference